Amadesi S.; Gatti M.; Rinaldi M.; Pea F.; Viale P.; Gaibani P., Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2024, 63, pp. 1 - 2 [articolo]
Bonazzetti, Cecilia; Rinaldi, Matteo; Cosentino, Federica; Gatti, Milo; Freire, Maristela Pinheiro; Mularoni, Alessandra; Clemente, Wanessa Trindade; Pierrotti, Ligia Camera; Aguado, Jose Maria; Grossi, Paolo; Pea, Federico; Viale, Pierluigi; Giannella, Maddalena, Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria, «TRANSPLANT INFECTIOUS DISEASE», 2024, 26, Article number: :e14238, pp. 1 - 10 [articolo]
Giacobbe, D. R.; Labate, L.; Russo Artimagnella, C.; Marelli, C.; Signori, A.; Di Pilato, V.; Aldieri, C.; Bandera, A.; Briano, F.; Cacopardo, B.; Calabresi, A.; Capra Marzani, F.; Carretta, A.; Cattelan, A.; Ceccarelli, L.; Cenderello, G.; Corcione, S.; Cortegiani, A.; Cultrera, R.; De Rosa, F. G.; Del Bono, V.; Del Puente, F.; Fanelli, C.; Fava, F.; Francisci, D.; Geremia, N.; Graziani, L.; Lombardi, A.; Losito, A. R.; Maida, I.; Marino, A.; Mazzitelli, M.; Merli, M.; Monardo, R.; Mularoni, A.; Oltolini, C.; Pallotto, C.; Pontali, E.; Raffaelli, F.; Rinaldi, M.; Ripa, M.; Santantonio, T. A.; Serino, F. S.; Spinicci, M.; Torti, C.; Trecarichi, E. M.; Tumbarello, M.; Mikulska, M.; Giacomini, M.; Marchese, A.; Vena, A.; Bassetti, M.; Murgia, Y.; Di Meco, G.; Cappello, A.; Guastavino, S.; Campi, C.; Piana, M.; Mora, S.; Rosso, N.; Di Biagio, A.; Viglietti, G.; Brunetti, I.; Robba, C.; Ball, L.; Battaglini, D.; Portunato, F.; Giannella, M.; Viale, P.; Viero, G.; Azzarà, C.; Bartoloni, A, Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study, «INFECTIOUS DISEASES AND THERAPY», 2024, 13, pp. 1929 - 1948 [articolo]Open Access
Gatti M.; Rinaldi M.; Gaibani P.; Siniscalchi A.; Tonetti T.; Giannella M.; Viale P.; Pea F., A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF), «JOURNAL OF CRITICAL CARE», 2023, 76, Article number: 154301, pp. 1 - 6 [articolo]Open Access
Gatti, Milo; Pascale, Renato; Cojutti, Pier Giorgio; Rinaldi, Matteo; Ambretti, Simone; Conti, Matteo; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 61, pp. 1 - 7 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; Gaibani, Paolo; Siniscalchi, Antonio; Tonetti, Tommaso; Viale, Pierluigi; Pea, Federico, A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 62, Article number: 106992, pp. 1 - 3 [articolo]
Giannella M.; Rinaldi M.; Viale P., Antimicrobial Resistance in Organ Transplant Recipients, «INFECTIOUS DISEASE CLINICS OF NORTH AMERICA», 2023, 37, pp. 515 - 537 [articolo]Open Access
Rinaldi M.; Campoli C.; Gallo M.; Marzolla D.; Zuppiroli A.; Riccardi R.; Casarini M.; Riccucci D.; Malosso M.; Bonazzetti C.; Pascale R.; Tazza B.; Pasquini Z.; Marconi L.; Curti S.; Giannella M.; Viale P., Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study, «BMC INFECTIOUS DISEASES», 2023, 23, Article number: 646, pp. 1 - 9 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections and/or Ventilator-Associated Pneumonia?, «ANTIBIOTICS», 2023, 12, Article number: 1736, pp. 1 - 10 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; Bonazzetti, Cecilia; Gaibani, Paolo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2023, 67, Article number: e0096923, pp. 1 - 12 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; Potena, Luciano; Salvaterra, Elena; Morelli, Maria Cristina; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients?, «TRANSPLANT INFECTIOUS DISEASE», 2023, -, Article number: e14107, pp. 1 - 8 [articolo]Open Access
Gatti, Milo; Bonazzetti, Cecilia; Tazza, Beatrice; Pascale, Renato; Miani, Beatrice; Malosso, Marta; Beci, Giacomo; Marzolla, Domenico; Rinaldi, Matteo; Viale, Pierluigi; Giannella, Maddalena, Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysis, «CLINICAL MICROBIOLOGY AND INFECTION», 2023, 29, pp. 1150 - 1158 [articolo]
Troisi, Carla; Cojutti, Pier Giorgio; Rinaldi, Matteo; Laici, Cristiana; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients, «PHARMACEUTICS», 2023, 15, Article number: 551, pp. 1 - 10 [articolo]Open Access
Berrino, Pasquale Maria; Gatti, Milo; Rinaldi, Matteo; Brunocilla, Eugenio; Viale, Pierluigi; Pea, Federico, Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections, «ANTIBIOTICS», 2023, 12, Article number: 1388, pp. 1 - 12 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; Gaibani, Paolo; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection: due to OXA-181-producing Klebsiella pneumoniae, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2023, 10.1016/j.jgar.2023.05.007, pp. 1 - 3 [articolo]Open Access
